Susan Gromacki, OD, MS, FAAO, FSLS, details one of her AAOpt 2026 sessions, titled "Advances in Contact Lens Care for the New Contact Lens Technologies." Kevin Chan, OD, MS, discusses an AAOpt 2026 ...
From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...
Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...
The approval gives eye care providers a new pharmacologic option for adults with presbyopia. Phentolamine is a non-selective alpha-1 and alpha-2 adrenergic antagonist, and the drug reduces pupil ...
Enspryng is the first subcutaneous, at-home treatment option for TED and the first interleukin (IL)-6 receptor inhibitor approved in the indication. The FDA has approved Enspryng (satralizumab, ...
Three researchers share the prize for discovering channelrhodopsin, a light-sensitive protein now being tested to restore vision in retinal disease. The Nobel Assembly at Karolinska Institutet ...
A handful of eye care providers spoke on the factors that have led to a lack of eye care access for World Sight Day.
The US FDA Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to review new drug application ...
For Maria Sampalis, OD, implementing AI isn't an excuse for practice owners to replace their staff with new technology; it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results